Non-functioning adrenal incidentalomas may increase toxic metabolites.

Background: Non-functioning adrenal incidentaloma (NFAI) is a frequent diagnosis with increasing radiological tests. The emerging shreds of evidence showed that they might have negative cardiometabolic effects. The study aimed to investigate whether the toxic metabolites, asymmetric dimethylarginine (ADMA) levels, were altered in NFAI patients.

Nonfunctional adrenal incidentalomas may be related to bisphenol-A.

Purpose: Bisphenol-A (BPA) is an endocrine-disrupting chemical that may affect the hormones and their receptors. The aim of this study is to determine whether BPA has an effect on the development of nonfunctional adrenal incidentaloma (NFAI).

Methods: Fifty patients who were admitted to endocrinology outpatient clinics and diagnosed as NFAI were included in the study.